Dolby Laboratories
$ 66.07
-0.33%
04 Dec - close price
- Market Cap 6,332,425,000 USD
- Current Price $ 66.07
- High / Low $ 66.86 / 65.90
- Stock P/E 25.22
- Book Value 27.47
- EPS 2.62
- Next Earning Report 2026-01-29
- Dividend Per Share $1.35
- Dividend Yield 2.04 %
- Next Dividend Date 2025-12-10
- ROA 0.06 %
- ROE 0.10 %
- 52 Week High 88.05
- 52 Week Low 63.68
About
Dolby Laboratories, Inc. (DLB) stands as a pivotal technology innovator in the realm of audio and visual experiences, significantly enhancing entertainment and communication quality across diverse platforms, including cinemas, home theaters, and mobile devices. Based in San Francisco, Dolby is recognized for its cutting-edge technologies such as Dolby Atmos and Dolby Vision, which set industry benchmarks for immersive soundscapes and high dynamic range imaging. With a strong focus on innovation backed by extensive research and strategic partnerships, Dolby Laboratories is well-positioned to capitalize on growth opportunities in the evolving digital media landscape, making it an attractive prospect for institutional investors in the technology and entertainment sectors.
Analyst Target Price
$90.50
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-18 | 2025-07-31 | 2025-04-30 | 2025-01-30 | 2024-11-19 | 2024-08-07 | 2024-05-02 | 2024-02-01 | 2023-11-16 | 2023-08-03 | 2023-05-04 | 2023-02-02 |
| Reported EPS | 0.99 | 0.48 | 1.34 | 1.14 | 0.81 | 0.71 | 1.27 | 1.01 | 0.65 | 0.55 | 1.26 | 1.11 |
| Estimated EPS | 0.7044 | 0.71 | 1.2667 | 0.9767 | 0.7 | 0.59 | 1.19 | 0.86 | 0.53 | 0.55 | 0.98 | 0.79 |
| Surprise | 0.2856 | -0.23 | 0.0733 | 0.1633 | 0.11 | 0.12 | 0.08 | 0.15 | 0.12 | 0 | 0.28 | 0.32 |
| Surprise Percentage | 40.5451% | -32.3944% | 5.7867% | 16.7196% | 15.7143% | 20.339% | 6.7227% | 17.4419% | 22.6415% | 0% | 28.5714% | 40.5063% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-01-29 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.15 |
| Currency | USD |
Previous Dividend Records
| Dec 2025 | Aug 2025 | May 2025 | Feb 2025 | Dec 2024 | Aug 2024 | May 2024 | Feb 2024 | Dec 2023 | Aug 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-10 | 2025-08-20 | 2025-05-21 | 2025-02-19 | 2024-12-10 | 2024-08-27 | 2024-05-22 | 2024-02-22 | 2023-12-05 | 2023-08-22 |
| Amount | $0.36 | $0.33 | $0.33 | $0.33 | $0.33 | $0.3 | $0.3 | $0.3 | $0.3 | $0.27 |
Next Dividend Records
| Dividend per share (year): | $1.35 |
| Dividend Yield | 2.04% |
| Next Dividend Date | 2025-12-10 |
| Ex-Dividend Date | 2025-12-02 |
Recent News: DLB
2025-11-24 23:54:00
Shriram Revankar, SVP at Dolby Laboratories, sold 3,000 shares of Class A Common Stock for $196,650 on November 21, 2025. This transaction occurred while Dolby shares were trading near their 52-week low, though InvestingPro data suggests the company is undervalued. Dolby Laboratories maintains strong financial health with impressive gross profit margins, more cash than debt, and a history of consistent dividend increases.
2025-11-18 23:51:34
Dolby Laboratories announced strong fourth quarter and fiscal year 2025 financial results, with total revenue reaching $307 million for Q4 and $1.35 billion for the full fiscal year. The company reported significant growth in Dolby Atmos, Dolby Vision, and imaging patents, expanding its market reach with new initiatives like Dolby OptiView. Dolby also provided an optimistic financial outlook for fiscal year 2026, anticipating continued revenue growth and operating margin improvements.
2025-10-23 00:00:00
TD Asset Management Inc significantly increased its stake in Dolby Laboratories, holding 16,700 shares valued at $1.24 million. Concurrently, several insiders, including CEO Kevin J. Yeaman, sold substantial amounts of Dolby Laboratories stock. The company reported a 9.2% year-over-year revenue increase and provided FY 2025 EPS guidance, while analysts maintain a "Moderate Buy" consensus rating for DLB.
2025-10-16 08:35:01
This page provides a brief summary of Dolby Laboratories (DLB) from Argus, noting its role in developing audio technologies. It displays current stock information including the price and a rating, while also highlighting the availability of premium research reports for subscribers. The article largely indicates that the primary content, likely a full report from Argus, is behind a paywall.
2025-10-14 22:24:26
This article indicates an "Application error" on the website, preventing access to the full content of an earnings call transcript for Dolby Labs. The title suggests Dolby Labs experienced a 9% revenue boost in Q3 2025. Due to the technical error, details of the earnings call are unavailable.
2025-10-11 17:02:25
Dolby Laboratories (NYSE:DLB) stock has hit a new 52-week low of $68.24, despite analysts maintaining a "Moderate Buy" rating with an average price target of $95.75. The company recently reported a 9.2% year-over-year increase in quarterly revenue and topped earnings estimates, with a positive earnings per share forecast for FY 2025. Institutional investors have seen some changes in holdings, with some increasing and others acquiring new positions in the company.
